Skip to main content
OpenTrials

Clinical trial condition

Blood-Borne Infections

Explore clinical trials studying Blood-Borne Infections. Study availability and eligibility vary by location and protocol.

8,270 public trials 443 recruiting studies
Refine in advanced search Browse all conditions

Blood-Borne Infections trial results

Completed

Amphotericin Alone or in Combination With Fluconazole for AIDS-Associated Meningitis

NCT00145249

Conditions
Bacterial Infections, Bacterial Infections and Mycoses, Blood-Borne Infections, +24 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • University of Southern California Los Angeles, California, United States
  • Harbor-UCLA Medical Center Los Angeles, California, United States
  • University of Colorado Denver, Colorado, United States
View all 15 locations
View Trial Details
Completed

H1N1 Vaccine at Two Dose Levels in HIV Positive Adults

NCT00992433

Conditions
Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +18 more
Locations
  • University of Iowa Iowa City, Iowa, United States
  • University of Maryland Baltimore - Institute of Human Virology Baltimore, Maryland, United States
  • Saint Louis University St Louis, Missouri, United States
  • Cincinnati Children's Hospital Medical Center Cincinnati, Ohio, United States
View Trial Details
Completed

Trial of Maraviroc (UK-427,857) in Combination With Optimized Background Therapy Versus Optimized Background Therapy Alone for the Treatment of HIV-1 Infected Subjects

NCT00098722

Conditions
Blood-Borne Infections, Communicable Diseases, Genital Diseases, +11 more
Locations
  • Pfizer Investigational Site Hobson City, Alabama, United States
  • Pfizer Investigational Site Garden Grove, California, United States
  • Pfizer Investigational Site Los Angeles, California, United States
  • Pfizer Investigational Site Oakland, California, United States
View all 172 locations
View Trial Details
Completed

A Study of PEGASYS (Peginterferon Alfa-2a (40KD)) Plus COPEGUS (Ribavirin) With or Without Pioglitazone in Treatment-Naive Patients With Chronic Hepatitis C and Insulin Resistance.

NCT00545233

Conditions
Blood-Borne Infections, Chronic Disease, Communicable Diseases, +14 more
Locations
  • Birmingham, Alabama, United States
  • Tucson, Arizona, United States
  • Anaheim, California, United States
  • Fresno, California, United States
View all 66 locations
View Trial Details

Related conditions